Neuralink's "Blindsight" device, developed by Elon Musk's company, aims to restore vision for blind individuals.

The regulatory approval is just the first phase of a long project, but Neuralink owner Elon Musk is already touting his brain ...

The program gives manufacturers better access to regulators and the ability to design more flexible clinical trials.

The device is a variant of Neuralink's brain implant technology, in this case designed to "enable even those who have lost both eyes" to see, according to owner Elon Musk. Separately, progress is ...

Developing advanced drug screening tools is crucial for the advancement of personalized medicine and the creation of more effective treatments. One organ receiving particular attention in this area is ...